These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 27167392)
1. Q&A: Bernard Munos. Bender E Nature; 2016 May; 533(7602):S59. PubMed ID: 27167392 [No Abstract] [Full Text] [Related]
2. [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness]. Hedner T; Gatenbeck L Lakartidningen; 2012 Jun 27-Jul 17; 109(26-28):1280-1. PubMed ID: 22852257 [No Abstract] [Full Text] [Related]
3. Ian Tomlinson. Tomlinson I Nat Rev Drug Discov; 2016 Mar; 15(3):154. PubMed ID: 26893183 [No Abstract] [Full Text] [Related]
4. Vertical disintegration: a strategy for pharmaceutical businesses in 2009? Dixon J; Lawton G; Machin P Nat Rev Drug Discov; 2009 Jun; 8(6):435. PubMed ID: 19483701 [No Abstract] [Full Text] [Related]
5. Competition: Unlikely partnerships. Savage N Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391 [No Abstract] [Full Text] [Related]
6. David Haslam. Interview by Asher Mullard. Haslam D Nat Rev Drug Discov; 2013 Jul; 12(7):500. PubMed ID: 23764976 [No Abstract] [Full Text] [Related]
7. [Open innovation and licensing in the pharmaceutical industry]. Yamasaki M Nihon Yakurigaku Zasshi; 2013 Jul; 142(1):28-31. PubMed ID: 23842225 [No Abstract] [Full Text] [Related]
8. Traditional drug-discovery model ripe for reform. Cressey D Nature; 2011 Mar; 471(7336):17-8. PubMed ID: 21368796 [No Abstract] [Full Text] [Related]
9. An open source pharma roadmap. Balasegaram M; Kolb P; McKew J; Menon J; Olliaro P; Sablinski T; Thomas Z; Todd MH; Torreele E; Wilbanks J PLoS Med; 2017 Apr; 14(4):e1002276. PubMed ID: 28419094 [TBL] [Abstract][Full Text] [Related]
10. Translational regenerative medicine research: essential to discovery and outcome. Mason C; Dunnill P Regen Med; 2007 May; 2(3):227-9. PubMed ID: 17511558 [No Abstract] [Full Text] [Related]
11. China spurs pharma innovation. Hughes B Nat Rev Drug Discov; 2010 Aug; 9(8):581-2. PubMed ID: 20671751 [No Abstract] [Full Text] [Related]
13. How informatics can potentiate precompetitive open-source collaboration to jump-start drug discovery and development. Perakslis ED; Van Dam J; Szalma S Clin Pharmacol Ther; 2010 May; 87(5):614-6. PubMed ID: 20376001 [No Abstract] [Full Text] [Related]
14. Novelty in the target landscape of the pharmaceutical industry. Agarwal P; Sanseau P; Cardon LR Nat Rev Drug Discov; 2013 Aug; 12(8):575-6. PubMed ID: 23903214 [No Abstract] [Full Text] [Related]